Immunosuppressive effects of cytosine arabinoside and methotrexate in man.
D000328:Adult; D000368:Aged; D000917:Antibody Formation / Q000187:drug effects*; D003561:Cytarabine / Q000627:therapeutic use*; D004926:Escherichia coli; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013745:Tetanus Toxoid
D007166:Immunosuppressive Agents; D013745:Tetanus Toxoid; D003561:Cytarabine; D008727:Methotrexate